Home » Newsletters » BioWorld Science

BioWorld Science

May 14, 2014

View Archived Issues

BACE1 inhibitor tested for retinal beta-amyloidosis

Safety and efficacy of anti-CHST15 dsRNA in patients with Crohn's disease

GeneSight pharmacogenomic test improves odds of response to antidepressants

Mitsubishi Tanabe Pharma reflects on accomplishments of fiscal 2013

BTZ-169 demonstrates significant efficacy for N. brasiliensis infection

Researchers present promising in vitro data for VCP-746

Dainippon Sumitomo Pharma offers overview of fiscal 2013

Excellagen selected for use with stem cells in E.U.-funded human study

Shin Poong's neuroprotective compound shows promising preclinical results

Jubilant Biosys and Orion form collaborative pain management program

Kythera Biopharmaceuticals submits ATX-101 NDA for submental fat reduction

MabVax Therapeutics and Telik agree to merge

Origenis researchers patent new protein kinase inhibitors

Roche discloses novel Abeta production inhibitors

Berg and Medical University of South Carolina form collaboration to discover lupus biomarkers

Janssen presents novel antivirals for RSV infection

Abbott reports results for investigational infection diagnostic

New agents for HCV infection disclosed by Merck & Co.

Aslan Pharmaceuticals and CSL to develop new therapy for asthma

Janssen submits sNDAs to FDA for Invega Sustenna

FDA clears transfer of orphan drug designation for intrathecal resiniferatoxin to Sorrento

Inovio acquires rights to preclinical therapies for Alzheimer's and MS

Lysosomal Therapeutics receives funding for neurodegenerative disease research

Xenetic Biosciences reports phase I results for oxyntomodulin analogue

Incyte and MedImmune to collaborate on cancer immunotherapy combination trial

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...